These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15379486)

  • 1. Amyloid-like formation by self-assembly of peptidolipids in two dimensions.
    Li C; Orbulescu J; Sui G; Leblanc RM
    Langmuir; 2004 Sep; 20(20):8641-5. PubMed ID: 15379486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface chemistry of Alzheimer's disease: a Langmuir monolayer approach.
    Thakur G; Micic M; Leblanc RM
    Colloids Surf B Biointerfaces; 2009 Dec; 74(2):436-56. PubMed ID: 19726167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine inhibits amyloid formation by the beta-peptide.
    Salomon AR; Marcinowski KJ; Friedland RP; Zagorski MG
    Biochemistry; 1996 Oct; 35(42):13568-78. PubMed ID: 8885836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
    Ha C; Ryu J; Park CB
    Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).
    Kuroda Y; Maeda Y; Hanaoka H; Miyamoto K; Nakagawa T
    J Pept Sci; 2004 Jan; 10(1):8-17. PubMed ID: 14959887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight.
    Davis TJ; Soto-Ortega DD; Kotarek JA; Gonzalez-Velasquez FJ; Sivakumar K; Wu L; Wang Q; Moss MA
    Mol Pharmacol; 2009 Aug; 76(2):405-13. PubMed ID: 19483107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling amyloid growth in multiple dimensions.
    Dong J; Lu K; Lakdawala A; Mehta AK; Lynn DG
    Amyloid; 2006 Dec; 13(4):206-15. PubMed ID: 17107881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template.
    Ha C; Park CB
    Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abeta-globulomers are formed independently of the fibril pathway.
    Gellermann GP; Byrnes H; Striebinger A; Ullrich K; Mueller R; Hillen H; Barghorn S
    Neurobiol Dis; 2008 May; 30(2):212-20. PubMed ID: 18353662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-amyloid fibril formation is promoted by step edges of highly oriented pyrolytic graphite.
    Losic D; Martin LL; Aguilar MI; Small DH
    Biopolymers; 2006; 84(5):519-26. PubMed ID: 16752395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations alter the geometry and mechanical properties of Alzheimer's Aβ(1-40) amyloid fibrils.
    Paparcone R; Pires MA; Buehler MJ
    Biochemistry; 2010 Oct; 49(41):8967-77. PubMed ID: 20731379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical manipulation of Alzheimer's amyloid beta1-42 fibrils.
    Karsai A; Mártonfalvi Z; Nagy A; Grama L; Penke B; Kellermayer MS
    J Struct Biol; 2006 Aug; 155(2):316-26. PubMed ID: 16713296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular dynamics approach to the structural characterization of amyloid aggregation.
    Cecchini M; Curcio R; Pappalardo M; Melki R; Caflisch A
    J Mol Biol; 2006 Apr; 357(4):1306-21. PubMed ID: 16483608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis.
    Wurth C; Guimard NK; Hecht MH
    J Mol Biol; 2002 Jun; 319(5):1279-90. PubMed ID: 12079364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High resolution scanning tunnelling microscopy of the beta-amyloid protein (Abeta1-40) of Alzheimer's disease suggests a novel mechanism of oligomer assembly.
    Losic D; Martin LL; Mechler A; Aguilar MI; Small DH
    J Struct Biol; 2006 Jul; 155(1):104-10. PubMed ID: 16650774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and biological activity of beta-sheet breaker peptide conjugates.
    Rocha S; Cardoso I; Börner H; Pereira MC; Saraiva MJ; Coelho M
    Biochem Biophys Res Commun; 2009 Mar; 380(2):397-401. PubMed ID: 19250644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational changes of the amyloid beta-peptide (1-40) adsorbed on solid surfaces.
    Giacomelli CE; Norde W
    Macromol Biosci; 2005 May; 5(5):401-7. PubMed ID: 15889393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.
    Schuster D; Rajendran A; Hui SW; Nicotera T; Srikrishnan T; Kruzel ML
    Neuropeptides; 2005 Aug; 39(4):419-26. PubMed ID: 15890402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.